Neuromyelitis Optica (NMO)
2 competing products in clinical development for Neuromyelitis Optica (NMO).
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Satralizumab + Placebo + Baseline Treatment | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Satralizumab + Placebo | Chugai Pharmaceutical | Phase 3 | Completed | 40 |